TTM
0.9%
YoY change
−1.74pp
Trough year (2000)
-0.9%
Peak year (1992)
9.2%
Latest annual
0.3%
FCF Margin history chart for Humana (HUM) from 1990 to 2025
Latest: 0.3%
FCF Margin change chart for Humana (HUM) from 1990 to 2025
Latest: −1.74pp
FCF Margin history table for Humana (HUM) from 1990 to 2025
| 2025 | 0.3% | -1.74pp | ||
| 2024 | 2.0% | -0.77pp | ||
| 2023 | 2.8% | -0.92pp | ||
| 2022 | 3.7% | +2.61pp | ||
| 2021 | 1.1% | -4.96pp | ||
| 2020 | 6.1% | -0.95pp | ||
| 2019 | 7.0% | +4.26pp | ||
| 2018 | 2.7% | -3.81pp | ||
| 2017 | 6.6% | +3.96pp | ||
| 2016 | 2.6% | +1.95pp | ||
| 2015 | 0.6% | -1.61pp | ||
| 2014 | 2.2% | -0.85pp | ||
| 2013 | 3.1% | -0.77pp | ||
| 2012 | 3.9% | -0.87pp | ||
| 2011 | 4.7% | -1.23pp | ||
| 2010 | 6.0% | +1.97pp | ||
| 2009 | 4.0% | +1.51pp | ||
| 2008 | 2.5% | -1.41pp | ||
| 2007 | 3.9% | -3.08pp | ||
| 2006 | 7.0% | +3.78pp | ||
| 2005 | 3.2% | +1.41pp | ||
| 2004 | 1.8% | -0.77pp | ||
| 2003 | 2.6% | +0.69pp | ||
| 2002 | 1.9% | +1.52pp | ||
| 2001 | 0.3% | +1.23pp | ||
| 2000 | -0.9% | -2.15pp | ||
| 1999 | 1.3% | +1.54pp | ||
| 1998 | -0.3% | -2.97pp | ||
| 1997 | 2.7% | -1.27pp | ||
| 1996 | 4.0% | +1.92pp | ||
| 1995 | 2.0% | -5.05pp | ||
| 1994 | 7.1% | +2.08pp | ||
| 1993 | 5.0% | -4.15pp | ||
| 1992 | 9.2% | +7.33pp | ||
| 1991 | 1.8% | -6.71pp | ||
| 1990 | 8.5% | — |
- 20250.3%-1.74pp
- 20242.0%-0.77pp
- 20232.8%-0.92pp
- 20223.7%+2.61pp
- 20211.1%-4.96pp
- 20206.1%-0.95pp
- 20197.0%+4.26pp
- 20182.7%-3.81pp
- 20176.6%+3.96pp
- 20162.6%+1.95pp
- 20150.6%-1.61pp
- 20142.2%-0.85pp
- 20133.1%-0.77pp
- 20123.9%-0.87pp
- 20114.7%-1.23pp
- 20106.0%+1.97pp
- 20094.0%+1.51pp
- 20082.5%-1.41pp
- 20073.9%-3.08pp
- 20067.0%+3.78pp
- 20053.2%+1.41pp
- 20041.8%-0.77pp
- 20032.6%+0.69pp
- 20021.9%+1.52pp
- 20010.3%+1.23pp
- 2000-0.9%-2.15pp
- 19991.3%+1.54pp
- 1998-0.3%-2.97pp
- 19972.7%-1.27pp
- 19964.0%+1.92pp
- 19952.0%-5.05pp
- 19947.1%+2.08pp
- 19935.0%-4.15pp
- 19929.2%+7.33pp
- 19911.8%-6.71pp
- 19908.5%—
FCF Margin values are taken from Humana's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About FCF Margin at Humana (HUM)
According to Humana's latest reported financial statements, the company's latest reported free cash flow margin is 0.9%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Humana (HUM) free cash flow margin totalled 0.29% – contracted 1.7 percentage points year-over-year.
9.15% stands as the all-time-high annual free cash flow margin, posted in 1992, against a low of -0.90% during 2000.
Humana FCF Margin by Year
Humana FCF Margin 2025: 0.3%
2025's free cash flow margin for Humana came in at 0.29%, contracted 1.7 percentage points from 2024.
Humana FCF Margin 2024: 2.0%
Humana posted free cash flow margin of 2.03% in 2024, contracted 0.8 percentage points from 2023.
Humana FCF Margin 2023: 2.8%
In 2023, Humana reported free cash flow margin of 2.80%, contracted 0.9 percentage points from 2022.
Humana FCF Margin 2022: 3.7%
Humana free cash flow margin in 2022 was 3.71%, expanded 2.6 percentage points from 2021.
Humana FCF Margin 2021: 1.1%
Humana free cash flow margin in 2021 was 1.10%.
See more financial history for Humana (HUM).
Sector peers by FCF Margin
Healthcare peers of Humana (HUM), ranked by their latest free cash flow margin
| 33.2% | |
| 23.1% | |
| 21.5% | |
| 18.8% | |
| 18.4% | |
| 15.1% | |
| 9.4% | |
| 4.4% |
- 33.2%
- 23.1%
- 21.5%
- 18.8%
- 15.1%
Frequently asked questions
Humana (HUM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation